BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 36695575)

  • 21. Conserved type III secretion system exerts important roles in Chlamydia trachomatis.
    Dai W; Li Z
    Int J Clin Exp Pathol; 2014; 7(9):5404-14. PubMed ID: 25337183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Type III Secretion Effector CteG Mediates Host Cell Lytic Exit of
    Pereira IS; Pais SV; Borges V; Borrego MJ; Gomes JP; Mota LJ
    Front Cell Infect Microbiol; 2022; 12():902210. PubMed ID: 35903198
    [No Abstract]   [Full Text] [Related]  

  • 23. Advances in genetic manipulation of
    Wan W; Li D; Li D; Jiao J
    Front Immunol; 2023; 14():1209879. PubMed ID: 37449211
    [No Abstract]   [Full Text] [Related]  

  • 24. Cross Talk between ARF1 and RhoA Coordinates the Formation of Cytoskeletal Scaffolds during Chlamydia Infection.
    Haines A; Wesolowski J; Ryan NM; Monteiro-Brás T; Paumet F
    mBio; 2021 Dec; 12(6):e0239721. PubMed ID: 34903051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chlamydia trachomatis Alters Mitochondrial Protein Composition and Secretes Effector Proteins That Target Mitochondria.
    Dimond Z; Bauler LD; Zhang Y; Carmody A; Hackstadt T
    mSphere; 2022 Dec; 7(6):e0042322. PubMed ID: 36286535
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of the Mitochondrion-Fatty Acid Axis for the Metabolic Reprogramming of Chlamydia trachomatis during Treatment with β-Lactam Antimicrobials.
    Shima K; Kaufhold I; Eder T; Käding N; Schmidt N; Ogunsulire IM; Deenen R; Köhrer K; Friedrich D; Isay SE; Grebien F; Klinger M; Richer BC; Günther UL; Deepe GS; Rattei T; Rupp J
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785629
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenic Puppetry: Manipulation of the Host Actin Cytoskeleton by
    Caven L; Carabeo RA
    Int J Mol Sci; 2019 Dec; 21(1):. PubMed ID: 31877733
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Loss of Expression of a Single Type 3 Effector (CT622) Strongly Reduces
    Cossé MM; Barta ML; Fisher DJ; Oesterlin LK; Niragire B; Perrinet S; Millot GA; Hefty PS; Subtil A
    Front Cell Infect Microbiol; 2018; 8():145. PubMed ID: 29868501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression and targeting of secreted proteins from Chlamydia trachomatis.
    Bauler LD; Hackstadt T
    J Bacteriol; 2014 Apr; 196(7):1325-34. PubMed ID: 24443531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Activation of neutrophils by Chlamydia trachomatis-infected epithelial cells is modulated by the chlamydial plasmid.
    Lehr S; Vier J; Häcker G; Kirschnek S
    Microbes Infect; 2018 May; 20(5):284-292. PubMed ID: 29499390
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Human Centrosomal Protein CCDC146 Binds
    Almeida F; Luís MP; Pereira IS; Pais SV; Mota LJ
    Front Cell Infect Microbiol; 2018; 8():254. PubMed ID: 30094225
    [No Abstract]   [Full Text] [Related]  

  • 32. Chlamydia trachomatis infection induces cleavage of the mitotic cyclin B1.
    Balsara ZR; Misaghi S; Lafave JN; Starnbach MN
    Infect Immun; 2006 Oct; 74(10):5602-8. PubMed ID: 16988235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific chlamydial inclusion membrane proteins associate with active Src family kinases in microdomains that interact with the host microtubule network.
    Mital J; Miller NJ; Fischer ER; Hackstadt T
    Cell Microbiol; 2010 Sep; 12(9):1235-49. PubMed ID: 20331642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Host cell death during infection with Chlamydia: a double-edged sword.
    Sixt BS
    FEMS Microbiol Rev; 2021 Jan; 45(1):. PubMed ID: 32897321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Chlamydia effector recruits CEP170 to reprogram host microtubule organization.
    Dumoux M; Menny A; Delacour D; Hayward RD
    J Cell Sci; 2015 Sep; 128(18):3420-34. PubMed ID: 26220855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Chlamydia trachomatis Tarp effector targets the Hippo pathway.
    Shehat MG; Aranjuez GF; Kim J; Jewett TJ
    Biochem Biophys Res Commun; 2021 Jul; 562():133-138. PubMed ID: 34052658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence that CT694 is a novel Chlamydia trachomatis T3S substrate capable of functioning during invasion or early cycle development.
    Hower S; Wolf K; Fields KA
    Mol Microbiol; 2009 Jun; 72(6):1423-37. PubMed ID: 19460098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effector proteins of Clamidia].
    Kariagina AS; Alekseevskiĭ AV; Spirin SA; Zigangirova NA; Gintsburg AL
    Mol Biol (Mosk); 2009; 43(6):963-83. PubMed ID: 20088373
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of Wnt Signaling Pathways Impairs
    Kintner J; Moore CG; Whittimore JD; Butler M; Hall JV
    Front Cell Infect Microbiol; 2017; 7():501. PubMed ID: 29322031
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of bovine lactoferrin on Chlamydia trachomatis infection and inflammation.
    Sessa R; Di Pietro M; Filardo S; Bressan A; Rosa L; Cutone A; Frioni A; Berlutti F; Paesano R; Valenti P
    Biochem Cell Biol; 2017 Feb; 95(1):34-40. PubMed ID: 28094551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.